Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cohbar Inc
(NQ:
CWBR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cohbar Inc
CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
November 27, 2023
From
CohBar, Inc.
Via
Business Wire
COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR
September 19, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
CohBar Reports Second Quarter 2023 Financial Results
August 14, 2023
From
CohBar, Inc.
Via
GlobeNewswire
CohBar Inc. (NASDAQ: CWBR) Leading the Way in Tuesday Trading Based on Percentage Gain
May 23, 2023
Via
Investor Brand Network
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CIRCOR International, Inc. (NYSE - CIR), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)
June 05, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)
June 05, 2023
From
CohBar, Inc.
Via
GlobeNewswire
COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR
May 30, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Embark Technology, Inc. (Nasdaq – EMBK), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)
May 30, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2023
From
CohBar, Inc.; Morphogenesis, Inc.
Via
GlobeNewswire
CWBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of CohBar, Inc. Is Fair to Shareholders
May 23, 2023
From
Halper Sadeh LLC
Via
Business Wire
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
May 23, 2023
From
CohBar, Inc.
Via
GlobeNewswire
CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
November 08, 2022
Conference call and webcast today at 5:00 p.m. ET, November 8, 2022
From
CohBar, Inc.
Via
GlobeNewswire
CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
October 26, 2022
Company to host conference call and webcast at 5:00 p.m. ET
From
CohBar, Inc.
Via
GlobeNewswire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
August 13, 2021
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.